WallStSmart

Medtronic PLC (MDT)vsVolitionrx Ltd (VNRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 2410498% more annual revenue ($35.48B vs $1.47M). MDT leads profitability with a 13.0% profit margin vs 0.0%. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

VNRX

Avoid

24

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued

Intrinsic value data unavailable for VNRX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

VNRX1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
32.2%10/10

Revenue surging 32.2% year-over-year

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

VNRX4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$27.26M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-7.3%2/10

ROE of -7.3% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : VNRX

The strongest argument for VNRX centers on Revenue Growth. Revenue growth of 32.2% demonstrates continued momentum.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : VNRX

The primary concerns for VNRX are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

MDT profiles as a value stock while VNRX is a hypergrowth play — different risk/reward profiles.

VNRX carries more volatility with a beta of 1.36 — expect wider price swings.

VNRX is growing revenue faster at 32.2% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 24/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Volitionrx Ltd

HEALTHCARE · MEDICAL DEVICES · USA

VolitionRx Limited, a multinational epigenetics company, is dedicated to developing blood tests to help diagnose a variety of cancers and other diseases globally. The company is headquartered in Austin, Texas.

Want to dig deeper into these stocks?